AzTrials
AzTrials

Binge Eating DisorderBEDNCT02868619

Binge Eating Disorder and Obesity : Functional MRI Study

A study testing Functional MRI, ADO-BEDS scale and R-CMAS scale in people with Binge Eating Disorder and Obesity, run by University Hospital, Montpellier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Obesity, defined as BMI> 30kg / m2, is a major public health problem, with devastating medical and psychological consequences. 30% of obese suffer from BED type of eating disorders. The optimal treatment of obesity remains bariatric surgery, failed in 20% of cases. Read more about this study

Who is it for?
Ages 12 to 16 yearsHealthy volunteers can take part
Conditions the study is for
Binge Eating Disorder, Obesity
What is being tested?
Functional MRI, ADO-BEDS scale and R-CMAS scale
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteFrance
Study dates
5 Dec 2014to 10 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 16 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Non specific inclusion criteria
  • Age limits ≥ 12 et < 16 years
  • Collection of the informed consent. For the minor patients, signature of parents
  • Affiliation or recipient with the mode of social security.
  • No associated evolutionary pathologies
  • Specific inclusion criteria for the patients
Show all 13Show fewer
  • Existence of a current food disorder of the conducts of type binge eating disorder according to the criteria Marcus and Kalarchian
  • Diagnosis of obesity defined by a body mass index > 97th percentile
  • Severity criteria defined by: Evolution of the obesity and the BED for at least 5 years AND Not answer to a dietary, pharmacological, psychotherapeutic care during at least 6 months
  • Specific inclusion criteria for the volunteers
  • Absence of a current food disorder of the conducts of type binge eating disorder according to the criteria Marcus and Kalarchian
  • Absence of antecedent of neurological disorder
  • an actual body mass index < 90th percentile

Who cannot join

  • IRM contraindication
  • Pacemaker
  • Port(Bearing) of surgical clips in the cervico-cephalic region or implanted medical surgical material(equipment) susceptible to mobilize under the influence of magnetic gradients
  • Intraocular foreign body
  • Metalic foreign body
  • claustrophobia
Show all 9Show fewer
  • The existence of possible psychiatric histories will be individually estimated
  • Pregnancy and breastfeeding
  • Loss of liberty by court or administrative order

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Montpellier

    Montpellier, 34295

Other trials in France

About this study

Official title: Binge Eating Disorder and Obesity : Reward System Abnormalities in Response to Food Stimuli and Research Operability by Deep Brain Stimulation Criteria: Functional MRI Study

Obesity, defined as BMI> 30kg / m2, is a major public health problem, with devastating medical and psychological consequences. 30% of obese suffer from BED type of eating disorders. The optimal treatment of obesity remains bariatric surgery, failed in 20% of cases. Many arguments are in favor of the involvement of the reward circuitry, with the central role of NAc in the pathophysiology of BED and obesity. The recent application and effectiveness of DBS (Deep Brain Stimulation) in refractory psychiatric disorders suggest that DBS may be of interest in treating obesity and BED with potential target for the NAc. This project propose to study fMRI activation of the reward system in response to food stimuli to better direct the DBS targets. This is a pilot study to define indication criteria based on fMRI to obese BED patients are potential candidates for treatment with DBS.

Read the detailed description

The aim of this functional neuroimaging study is to analyze brain responses to visual food cues in obese (body mass index > 97th percentile) adolescents with BED (according to the criteria Marcus and Kalarchian) compared with healthy control adolescents in two situations : hunger et satiety.

Fifteen obese adolescents (12/16 years) with BED and fifteen healthy control adolescents will be enrolled in the study protocol. Participants will be instructed not to eat food for at least 6 hours prior to the first imaging session. After the initial set of functional and anatomic scans, participants will be fed a standard calorie meal. Approximately 1 hour later, the experiment will be repeated while participants are in a satiated condition. The cortical fMRI activation will be measured during the following four experimental visual conditions : high calory food, low calory food, disgust and neutral presented in block design.

First-level and second-level differences in neural activation assessed during functional MRI in the different conditions will then be analyzed.

Being tested
Functional MRI, ADO-BEDS scale, R-CMAS scale
Keywords
fMRI, Deep brain stimulation, Food, Eating, Reward
Medical subject headings
Binge-Eating Disorder, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Functional MRIOther

    functional MRI assessed on all the volunteers in condition of hunger and in Condition of satiety

  • ADO-BEDS scaleOther

    Evaluate the severity of BED according to Marcus and Kalarchian temporary diagnosis criteria

  • R-CMAS scaleOther

    Evaluate the anxiety

Study groups in NCT02868619
Study groupRoleWhat they receive
Healthy controlsOtherNon obese adolescents without Binge Eating Disorder (BED)
Receives: Other: Functional MRI; Other: ADO-BEDS scale; Other: R-CMAS scale
Patients with BEDOtherObese adolescents with BED with Binge Eating Disorder (BED)
Receives: Other: Functional MRI; Other: ADO-BEDS scale; Other: R-CMAS scale

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in neural activation assessed during functional MRI

    The main objective of this study is the identification in patients with obesity and Binge Eating Disorder (BED) of functional MRI activation profiles (reward system) in response to food stimuli. The activation profiles will be analyzed by varying physiological conditions of hunger and satiety, and motivational value attributed to the food (calorie).

    Measured: 4 years

Secondary outcomes (1)
  1. Pairwise comparisons in neural activation assessed during functional MRI

    Further pairwise comparisons in neural activation assessed during functional MRI help to define DBS indication criteria / operability for BED obese candidates.

    Measured: 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2016 (estimated)
  2. Study start5 Dec 2014
  3. Primary completion10 Mar 2021
  4. Study completion10 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02868619
Sponsor's protocol ID
9093
Acronym
BED
Status last verified
May 2021
First submitted
8 Aug 2016
Last updated
18 May 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Charroud C, Poulen G, Sanrey E, Menjot de Champfleur N, Deverdun J, Coubes P, Le Bars E. Task- and Rest-based Functional Brain Connectivity in Food-related Reward Processes among Healthy Adolescents. Neuroscience. 2021 Mar 1;457:196-205. doi: 10.1016/j.neuroscience.2021.01.016. Epub 2021 Jan 21.

    PubMed 33484819
  • Charroud C, Menjot de Champfleur N, Sanrey E, Pfeuffer J, Deverdun J, Le Bars E, Coubes P. Differential effects of hunger on cerebral blood flow in healthy adolescents. Behav Brain Res. 2020 Apr 6;383:112505. doi: 10.1016/j.bbr.2020.112505. Epub 2020 Jan 23.

    PubMed 31982461

Questions about this trial

What is this clinical trial studying?

A study testing Functional MRI, ADO-BEDS scale and R-CMAS scale in people with Binge Eating Disorder and Obesity, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in neural activation assessed during functional MRI (time frame: 4 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02868619, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in